Imaging Technology
NOVEMBER 8, 2023
milla1cf Wed, 11/08/2023 - 13:01 November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission tomography (PET) scans of the heart may identify people who will go on to develop Parkinson’s disease or Lewy body dementia among those at-risk for these diseases.
AuntMinnie
OCTOBER 27, 2023
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. The full report is available here.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
OCTOBER 19, 2023
Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. The Sporadic Early-onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cohort.
Imaging Technology
OCTOBER 20, 2023
milla1cf Fri, 10/20/2023 - 18:30 October 20, 2023 — Meilleur Technologies, Inc. Amyloid plaques are a hallmark of several neurodegenerative diseases, including Alzheimer’s Disease (AD). The collaboration is focused on using [F-18]NAV-4694 as an imaging biomarker in ADNI4’s neurodegenerative disease research.
AuntMinnie
FEBRUARY 12, 2024
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University. “In
Vesta Teleradiology
DECEMBER 29, 2023
As we bid adieu to the final moments of 2023, it’s a great time to reflect on advancements and studies that have redefined the world of imaging this year. Check out our previous articles highlighting the impact that ChatGPT and Bard have made in 2023.
Imaging Technology
APRIL 28, 2023
ALISA), a joint venture between Life Healthcare and the AXIM Group of Companies, to expand provision of molecular imaging in South Africa with the delivery of two Cyclotrons, which produce radioisotopes enabling the production of tracing agents used in molecular imaging scans. It can allow early and precise diagnosis.
Expert insights. Personalized for you.
52 
Let's personalize your content